Medical - Healthcare Information Services
Build Your Comparison
Side-by-side financial analysisStock Comparison
CTEV vs EHTH vs KO vs HIMS vs TDOC
Revenue, margins, valuation, and 5-year total return — side by side.
Insurance - Brokers
Beverages - Non-Alcoholic
Medical - Equipment & Services
Medical - Healthcare Information Services
CTEV vs EHTH vs KO vs HIMS vs TDOC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Medical - Healthcare Information Services | Insurance - Brokers | Beverages - Non-Alcoholic | Medical - Equipment & Services | Medical - Healthcare Information Services |
| Market Cap | $502M | $51M | $341.71B | $7.79B | $1.46B |
| Revenue (TTM) | $979M | $529M | $49.28B | $2.37B | $2.51B |
| Net Income (TTM) | $-287M | $33M | $13.70B | $-13M | $-171M |
| Gross Margin | 61.1% | 98.8% | 61.7% | 67.6% | 65.6% |
| Operating Margin | 4.3% | 12.6% | 29.3% | 1.3% | -7.6% |
| Forward P/E | — | — | 24.3x | 69.5x | — |
| Total Debt | $4.63B | $134M | $45.49B | $1.26B | $1.04B |
| Cash & Equiv. | $17M | $74M | $10.27B | $229M | $781M |
CTEV vs EHTH vs KO vs HIMS vs TDOC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Feb 25 | Jun 26 | Return |
|---|---|---|---|
| Claritev Corporation (CTEV) | 100 | 140.2 | +40.2% |
| eHealth, Inc. (EHTH) | 100 | 18.7 | -81.3% |
| The Coca-Cola Compa… (KO) | 100 | 111.5 | +11.5% |
| Hims & Hers Health,… (HIMS) | 100 | 78.7 | -21.3% |
| Teladoc Health, Inc. (TDOC) | 100 | 84.4 | -15.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CTEV vs EHTH vs KO vs HIMS vs TDOC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CTEV lags the leaders in this set but could rank higher in a more targeted comparison.
EHTH is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.
- Dividend streak 3 yrs, beta 1.68, yield 11.7%
- Lower volatility, beta 1.68, Low D/E 13.8%, current ratio 3.37x
- Beta 1.68, yield 11.7%, current ratio 3.37x
- Beta 1.68 vs HIMS's 2.53, lower leverage
KO carries the broadest edge in this set and is the clearest fit for value and quality.
- Lower P/E (24.3x vs 69.5x)
- 27.8% margin vs CTEV's -29.3%
- +17.7% vs EHTH's -59.5%
- 13.1% ROA vs TDOC's -5.9%, ROIC 15.8% vs -11.5%
HIMS ranks third and is worth considering specifically for growth exposure and long-term compounding.
- Rev growth 59.0%, EPS growth -3.8%, 3Y rev CAGR 64.5%
- 261.9% 10Y total return vs KO's 115.0%
- 59.0% revenue growth vs TDOC's -1.5%
Among these 5 stocks, TDOC doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 59.0% revenue growth vs TDOC's -1.5% | |
| Value | Lower P/E (24.3x vs 69.5x) | |
| Quality / Margins | 27.8% margin vs CTEV's -29.3% | |
| Stability / Safety | Beta 1.68 vs HIMS's 2.53, lower leverage | |
| Dividends | 11.7% yield, 3-year raise streak, vs KO's 2.6%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +17.7% vs EHTH's -59.5% | |
| Efficiency (ROA) | 13.1% ROA vs TDOC's -5.9%, ROIC 15.8% vs -11.5% |
CTEV vs EHTH vs KO vs HIMS vs TDOC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
CTEV vs EHTH vs KO vs HIMS vs TDOC — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
KO leads in 3 of 6 categories
EHTH leads 1 • HIMS leads 1 • CTEV leads 0 • TDOC leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
KO leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
KO is the larger business by revenue, generating $49.3B annually — 93.2x EHTH's $529M. KO is the more profitable business, keeping 27.8% of every revenue dollar as net income compared to CTEV's -29.3%. On growth, KO holds the edge at +12.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $979M | $529M | $49.3B | $2.4B | $2.5B |
| EBITDAEarnings before interest/tax | $490M | $80M | $15.5B | $99M | $42M |
| Net IncomeAfter-tax profit | -$287M | $33M | $13.7B | -$13M | -$171M |
| Free Cash FlowCash after capex | -$39M | -$75M | $12.6B | $76M | $251M |
| Gross MarginGross profit ÷ Revenue | +61.1% | +98.8% | +61.7% | +67.6% | +65.6% |
| Operating MarginEBIT ÷ Revenue | +4.3% | +12.6% | +29.3% | +1.3% | -7.6% |
| Net MarginNet income ÷ Revenue | -29.3% | +6.3% | +27.8% | -0.6% | -6.8% |
| FCF MarginFCF ÷ Revenue | -4.0% | -14.3% | +25.5% | +3.2% | +10.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | +5.8% | -22.2% | +12.1% | +3.8% | -2.5% |
| EPS Growth (YoY)Latest quarter vs prior year | -0.7% | -72.7% | +18.2% | -3.0% | +32.1% |
Valuation Metrics
EHTH leads this category, winning 3 of 5 comparable metrics.
Valuation Metrics
At 26.1x trailing earnings, KO trades at a 62% valuation discount to HIMS's 69.5x P/E. On an enterprise value basis, EHTH's 1.4x EV/EBITDA is more attractive than HIMS's 55.1x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $502M | $51M | $341.7B | $7.8B | $1.5B |
| Enterprise ValueMkt cap + debt − cash | $5.1B | $112M | $376.9B | $8.8B | $1.7B |
| Trailing P/EPrice ÷ TTM EPS | -1.70x | -4.85x | 26.12x | 69.55x | -7.08x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 24.27x | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | 2.34x | — | — |
| EV / EBITDAEnterprise value multiple | 10.37x | 1.36x | 25.45x | 55.10x | 17.12x |
| Price / SalesMarket cap ÷ Revenue | 0.52x | 0.09x | 7.13x | 3.32x | 0.58x |
| Price / BookPrice ÷ Book value/share | — | 0.05x | 9.99x | 16.93x | 1.03x |
| Price / FCFMarket cap ÷ FCF | — | — | 64.52x | 105.30x | 5.10x |
Profitability & Efficiency
KO leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
KO delivers a 41.1% return on equity — every $100 of shareholder capital generates $41 in annual profit, vs $-12 for TDOC. EHTH carries lower financial leverage with a 0.14x debt-to-equity ratio, signaling a more conservative balance sheet compared to HIMS's 2.34x. On the Piotroski fundamental quality scale (0–9), KO scores 7/9 vs EHTH's 2/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | — | +4.0% | +41.1% | -2.5% | -12.4% |
| ROA (TTM)Return on assets | -5.8% | +2.9% | +13.1% | -0.6% | -5.9% |
| ROICReturn on invested capital | +0.7% | +6.1% | +15.8% | +8.6% | -11.5% |
| ROCEReturn on capital employed | +0.9% | +6.2% | +17.3% | +9.4% | -10.0% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 2 | 7 | 4 | 6 |
| Debt / EquityFinancial leverage | — | 0.14x | 1.33x | 2.34x | 0.75x |
| Net DebtTotal debt minus cash | $4.6B | $61M | $35.2B | $1.0B | $259M |
| Cash & Equiv.Liquid assets | $17M | $74M | $10.3B | $229M | $781M |
| Total DebtShort + long-term debt | $4.6B | $134M | $45.5B | $1.3B | $1.0B |
| Interest CoverageEBIT ÷ Interest expense | 0.18x | 5.03x | 10.70x | — | -8.76x |
Total Returns (Dividends Reinvested)
HIMS leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HIMS five years ago would be worth $31,955 today (with dividends reinvested), compared to $270 for EHTH. Over the past 12 months, KO leads with a +17.7% total return vs EHTH's -59.5%. The 3-year compound annual growth rate (CAGR) favors HIMS at 62.0% vs EHTH's -43.8% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -13.2% | -61.3% | +16.4% | +6.2% | +14.5% |
| 1-Year ReturnPast 12 months | -27.1% | -59.5% | +17.7% | -41.9% | +15.1% |
| 3-Year ReturnCumulative with dividends | +0.8% | -82.2% | +39.3% | +324.8% | -67.6% |
| 5-Year ReturnCumulative with dividends | +0.8% | -97.3% | +65.3% | +219.5% | -94.8% |
| 10-Year ReturnCumulative with dividends | +0.8% | -88.3% | +115.0% | +261.9% | -37.7% |
| CAGR (3Y)Annualised 3-year return | +0.3% | -43.8% | +11.7% | +62.0% | -31.3% |
Risk & Volatility
KO leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
KO is the less volatile stock with a -0.23 beta — it tends to amplify market swings less than HIMS's 2.53 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. KO currently trades 94.5% from its 52-week high vs EHTH's 28.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.26x | 1.68x | -0.23x | 2.53x | 1.82x |
| 52-Week HighHighest price in past year | $74.07 | $5.89 | $84.04 | $70.43 | $9.77 |
| 52-Week LowLowest price in past year | $11.50 | $1.20 | $65.35 | $13.74 | $4.40 |
| % of 52W HighCurrent price vs 52-week peak | +39.7% | +28.0% | +94.5% | +50.4% | +82.6% |
| RSI (14)Momentum oscillator 0–100 | 58.6 | 47.8 | 49.2 | 64.5 | 62.9 |
| Avg Volume (50D)Average daily shares traded | 139K | 376K | 13.6M | 25.0M | 4.5M |
Analyst Outlook
Evenly matched — EHTH and KO each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CTEV as "Buy", KO as "Buy", HIMS as "Hold", TDOC as "Hold". Consensus price targets imply 33.4% upside for CTEV (target: $39) vs -20.8% for HIMS (target: $28). For income investors, EHTH offers the higher dividend yield at 11.73% vs KO's 2.56%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | — | Buy | Hold | Hold |
| Price TargetConsensus 12-month target | $39.25 | — | $86.13 | $28.08 | $7.40 |
| # AnalystsCovering analysts | 4 | — | 48 | 20 | 42 |
| Dividend YieldAnnual dividend ÷ price | — | +11.7% | +2.6% | — | — |
| Dividend StreakConsecutive years of raises | — | 3 | 56 | — | — |
| Dividend / ShareAnnual DPS | — | $0.19 | $2.04 | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +4.8% | +0.2% | +1.2% | 0.0% |
KO leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). EHTH leads in 1 (Valuation Metrics). 1 tied.
CTEV vs EHTH vs KO vs HIMS vs TDOC: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CTEV or EHTH or KO or HIMS or TDOC a better buy right now?
For growth investors, Hims & Hers Health, Inc.
(HIMS) is the stronger pick with 59. 0% revenue growth year-over-year, versus -1. 5% for Teladoc Health, Inc. (TDOC). The Coca-Cola Company (KO) offers the better valuation at 26. 1x trailing P/E (24. 3x forward), making it the more compelling value choice. Analysts rate Claritev Corporation (CTEV) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CTEV or EHTH or KO or HIMS or TDOC?
On trailing P/E, The Coca-Cola Company (KO) is the cheapest at 26.
1x versus Hims & Hers Health, Inc. at 69. 5x.
03Which is the better long-term investment — CTEV or EHTH or KO or HIMS or TDOC?
Over the past 5 years, Hims & Hers Health, Inc.
(HIMS) delivered a total return of +219. 5%, compared to -97. 3% for eHealth, Inc. (EHTH). Over 10 years, the gap is even starker: HIMS returned +261. 9% versus EHTH's -88. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CTEV or EHTH or KO or HIMS or TDOC?
By beta (market sensitivity over 5 years), The Coca-Cola Company (KO) is the lower-risk stock at -0.
23β versus Hims & Hers Health, Inc. 's 2. 53β — meaning HIMS is approximately -1184% more volatile than KO relative to the S&P 500. On balance sheet safety, eHealth, Inc. (EHTH) carries a lower debt/equity ratio of 14% versus 2% for Hims & Hers Health, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CTEV or EHTH or KO or HIMS or TDOC?
By revenue growth (latest reported year), Hims & Hers Health, Inc.
(HIMS) is pulling ahead at 59. 0% versus -1. 5% for Teladoc Health, Inc. (TDOC). On earnings-per-share growth, the picture is similar: Claritev Corporation grew EPS 83. 0% year-over-year, compared to -3. 8% for Hims & Hers Health, Inc.. Over a 3-year CAGR, HIMS leads at 64. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CTEV or EHTH or KO or HIMS or TDOC?
The Coca-Cola Company (KO) is the more profitable company, earning 27.
3% net margin versus -29. 4% for Claritev Corporation — meaning it keeps 27. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: KO leads at 28. 7% versus -10. 4% for TDOC. At the gross margin level — before operating expenses — EHTH leads at 97. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CTEV or EHTH or KO or HIMS or TDOC more undervalued right now?
Analyst consensus price targets imply the most upside for CTEV: 33.
4% to $39. 25.
08Which pays a better dividend — CTEV or EHTH or KO or HIMS or TDOC?
In this comparison, EHTH (11.
7% yield), KO (2. 6% yield) pay a dividend. CTEV, HIMS, TDOC do not pay a meaningful dividend and should not be held primarily for income.
09Is CTEV or EHTH or KO or HIMS or TDOC better for a retirement portfolio?
For long-horizon retirement investors, The Coca-Cola Company (KO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
23), 2. 6% yield, +115. 0% 10Y return). Claritev Corporation (CTEV) carries a higher beta of 2. 26 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (KO: +115. 0%, CTEV: +0. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CTEV and EHTH and KO and HIMS and TDOC?
These companies operate in different sectors (CTEV (Healthcare) and EHTH (Financial Services) and KO (Consumer Defensive) and HIMS (Healthcare) and TDOC (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: CTEV is a small-cap quality compounder stock; EHTH is a small-cap income-oriented stock; KO is a large-cap quality compounder stock; HIMS is a small-cap high-growth stock; TDOC is a small-cap quality compounder stock. EHTH, KO pay a dividend while CTEV, HIMS, TDOC do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.